{"disease":{"id":"neoantigen","name":"neoantigen"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06675201","title":"Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":165,"lead_sponsor_name":"Sichuan University","has_results":false},{"nct_id":"NCT05498168","title":"Computational Prediction and Experimental Validation of Esophageal Cancer Associated Neoantigens","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"University Medical Center Ho Chi Minh City (UMC)","has_results":false},{"nct_id":"NCT05498194","title":"Computational Prediction and Experimental Validation of Gastric Cancer Associated Neoantigens","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"University Medical Center Ho Chi Minh City (UMC)","has_results":false},{"nct_id":"NCT07067385","title":"Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT03953235","title":"A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Gritstone bio, Inc.","has_results":false},{"nct_id":"NCT04145232","title":"AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Ardigen","has_results":false},{"nct_id":"NCT06499025","title":"Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL)","phase":"EARLY_PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":16,"lead_sponsor_name":"BGI, China","has_results":false},{"nct_id":"NCT04923802","title":"Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)","phase":"","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"GeneCast Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT06682117","title":"A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor","phase":"NA","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"Fudan University","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}